Amneal Pharmaceuticals, Inc. (AMRX) Stock Forecast
Data as of May 3, 2026Healthcare · Current price $12.84 (-0.27%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Apr 17, 2026 | Ashwani Verma | UBS | $19.00 | +48.0% |
| Mar 2, 2026 | Les Sulewski | Truist Financial | $17.00 | +32.5% |
| Nov 11, 2024 | David Amsellem | Piper Sandler | $11.00 | -14.3% |
| Oct 2, 2024 | Les Sulewski | Truist Financial | $12.00 | -6.5% |
| Oct 1, 2024 | Les Sulewski | Truist Financial | $10.00 | -22.1% |
| May 3, 2024 | Les Sulewski | Truist Financial | $9.00 | -29.9% |
| Mar 21, 2024 | David Amsellem | Piper Sandler | $8.00 | -37.7% |
Top Analysts Covering AMRX
AMRX vs Sector & Market
| Metric | AMRX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +32.5% | +1150.2% | +14.9% |
| P/E Ratio | 28.09 | 6.84 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $743M | $759M | $774M | 3 |
| 2026-09-30 | $795M | $810M | $830M | 1 |
| 2026-12-31 | $806M | $822M | $842M | 2 |
| 2027-03-31 | $755M | $770M | $788M | 1 |
| 2027-06-30 | $777M | $792M | $811M | 2 |
| 2027-09-30 | $833M | $849M | $870M | 2 |
| 2027-12-31 | $879M | $896M | $918M | 1 |
| 2028-12-31 | $3.53B | $3.56B | $3.60B | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.20 | $0.23 | $0.25 | 4 |
| 2026-09-30 | $0.27 | $0.28 | $0.28 | 1 |
| 2026-12-31 | $0.30 | $0.31 | $0.32 | 2 |
| 2027-03-31 | $0.25 | $0.25 | $0.26 | 2 |
| 2027-06-30 | $0.27 | $0.28 | $0.28 | 1 |
| 2027-09-30 | $0.31 | $0.32 | $0.33 | 1 |
| 2027-12-31 | $0.34 | $0.35 | $0.36 | 2 |
| 2028-12-31 | $1.35 | $1.37 | $1.39 | 1 |
Frequently Asked Questions
What is the analyst consensus for AMRX?
The consensus among 1 analysts covering Amneal Pharmaceuticals, Inc. (AMRX) is Buy with an average price target of $17.00.
What is the highest price target for AMRX?
The highest price target for AMRX is $19.00, set by Ashwani Verma at UBS on 2026-04-17.
What is the lowest price target for AMRX?
The lowest price target for AMRX is $8.00, set by David Amsellem at Piper Sandler on 2024-03-21.
How many analysts cover AMRX?
1 analysts have issued ratings for Amneal Pharmaceuticals, Inc. in the past 12 months.
Is AMRX a buy or sell right now?
Based on 1 analyst ratings, AMRX has a consensus rating of Buy (2.00/5) with a +32.5% upside to the consensus target of $17.00.
What are the earnings estimates for AMRX?
Analysts estimate AMRX will report EPS of $0.23 for the period ending 2026-06-30, with revenue estimated at $759M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.